ArticleCardiology research and practice2026
Establishment and Validation of Nomogram Model Based on Neutrophil Lymphocyte Ratio for Prognosis of Patients With Congestive Heart Failure.
Article in Cardiology research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Establishment and Validation of Nomogram Model Based on Neutrophil Lymphocyte Ratio for Prognosis of Patients With Congestive Heart Failure.Cardiology research and practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Based on the NLR, we aim to investigate the prognostic factors of CHF and establish a nomogram model to predict the OS of CHF patients. Methods: We selected 566 CHF patients from the NHANES database surveyed between 1999 and 2018 as the study population and randomly divided the data into training and validation sets in a 7:3 ratio. We used multivariate Cox regression analysis to determine the factors affecting the prognosis of CHF patients. Additionally, we evaluated the stratification of the NLR and the nomogram total risk score using the Kaplan-Meier survival curves and log-rank tests. To evaluate the predictive accuracy of the nomogram, we used the area under the ROC and the calibration curve method. Finally, we used decision curve analysis to explore the value of the nomogram in clinical applications. Results: Multivariate Cox regression analysis revealed that the NLR, age, and gender were risk factors affecting the OS of CHF patients, whereas hemoglobin and platelets were protective factors. We established a nomogram based on NLR, age, gender, hemoglobin, and platelets and calculated the area under the survival rate curve for 3, 5, and 10 years in both the training and validation sets, indicating good predictive capacity of the model (training set AUCs were 0.822, 0.82, and 0.803, respectively; validation set AUCs were 0.726, 0.769, and 0.775, respectively). Calibration curves and decision curve analysis indicated the model's accuracy and clinical applicability. The risk stratification was performed using NLR and the nomogram total score, and the Kaplan-Meier survival curves and log-rank tests showed that CHF patients with higher NLR had worse prognosis and those with lower nomogram total score had better prognosis than those in high-risk groups. There was a significant difference in OS between the high- and low-risk groups ( Conclusion: This study found that NLR, age, gender, hemoglobin, and platelets are closely related to the prognosis of CHF patients. We successfully constructed a nomogram model based on these factors, which can accurately predict the prognosis of CHF patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.